open access

Vol 78, No 11 (2007)
ARTICLES
Get Citation

Genital warts associated with HPV infection during II and III trimester of pregnancy – a case report and analysis of treatment options

Wioletta Rozmus-Warcholińska, Tomasz Loch, Bartosz Czuba, Urszula Mazurek, Jan Mucha, Dariusz Dworak, Krzysztof Sodowski
Ginekol Pol 2007;78(11).

open access

Vol 78, No 11 (2007)
ARTICLES

Abstract

More than 30 HPV types can infect the genital tract. Viral infection can be present in clinical, subclinical or latent form. A visible genital form of HPV infection are genital warts, which are commonly caused by HPV types 6 and 11, and appear on the vulva, cervix, vagina, urethra and anus. Oncogenic HPV types 16,18,31,33 and 35 are also found in genital warts and are associated with vulval (VIN), cervical (CIN) and anal (AIN) intraepithelial neoplasia. The general prevalence of HPV infection in the form of visible genital warts estimates to about 1% of sexually active adults. Approximately 15% of the infected group / of all adults have a subclinical or latent infection and at least 80% had been infected with one or more genital HPV types at some point in their lives. The highest rate of frequency of infections occurs in the group of adults, aged from 18 to 28. Over the last twenty years figures have shown a constant growth of the infection rate, which also includes pregnant women. Genital warts can proliferate during pregnancy due to altered immunity and increased blood supply. Cryotherapy, electrocautery, laser therapy, surgery or trichloroacetic acid may be used to remove the warts. In the paper a case report on genital warts associated with HPV infection during II and III trimester of pregnancy and analysis of treatment options has been presented.

Abstract

More than 30 HPV types can infect the genital tract. Viral infection can be present in clinical, subclinical or latent form. A visible genital form of HPV infection are genital warts, which are commonly caused by HPV types 6 and 11, and appear on the vulva, cervix, vagina, urethra and anus. Oncogenic HPV types 16,18,31,33 and 35 are also found in genital warts and are associated with vulval (VIN), cervical (CIN) and anal (AIN) intraepithelial neoplasia. The general prevalence of HPV infection in the form of visible genital warts estimates to about 1% of sexually active adults. Approximately 15% of the infected group / of all adults have a subclinical or latent infection and at least 80% had been infected with one or more genital HPV types at some point in their lives. The highest rate of frequency of infections occurs in the group of adults, aged from 18 to 28. Over the last twenty years figures have shown a constant growth of the infection rate, which also includes pregnant women. Genital warts can proliferate during pregnancy due to altered immunity and increased blood supply. Cryotherapy, electrocautery, laser therapy, surgery or trichloroacetic acid may be used to remove the warts. In the paper a case report on genital warts associated with HPV infection during II and III trimester of pregnancy and analysis of treatment options has been presented.
Get Citation

Keywords

PCR, genital warts, pregnancy

About this article
Title

Genital warts associated with HPV infection during II and III trimester of pregnancy – a case report and analysis of treatment options

Journal

Ginekologia Polska

Issue

Vol 78, No 11 (2007)

Bibliographic record

Ginekol Pol 2007;78(11).

Keywords

PCR
genital warts
pregnancy

Authors

Wioletta Rozmus-Warcholińska
Tomasz Loch
Bartosz Czuba
Urszula Mazurek
Jan Mucha
Dariusz Dworak
Krzysztof Sodowski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl